Zymeworks' lead candidate shows positive action in early-stage study; shares up 1% [Seeking Alpha]
Zymeworks Inc. (ZYME)
Last zymeworks inc. earnings: 3/2 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.zymeworks.com/overview
Company Research
Source: Seeking Alpha
Zymeworks' lead candidate shows positive action in early-stage study; shares up 1%Preliminary results from a Phase 1 dose-escalation study evaluating Zymeworks' (ZYME+1%) lead candidate ZW25 in patients with HER2-expressing cancers showed a treatment effect. The data will be presented on Friday, December 8 at the San Antonio Breast Cancer Symposium.A total of 22 patients are enrolled, 11 with breast cancer, eight with gastric, gastroesophageal junction or esophageal (GE) cancer and three with other HER2-expressing cancers.The partial response rate was 27% (n=6/22) across all dose groups. In breast cancer patients who received a median of six prior lines of HER2-targeted therapy, the partial response rate was 56% (n=5/9) in those with measurable disease with 89% (n=8/9) showing decreases in target lesions.Three HER2-high GE cancer patients with measurable disease showed tumor shrinkage, including one partial responder and one with stable disease after six months.79% (n=11/14) of breast
Show less
Read more
Impact Snapshot
Event Time:
ZYME
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYME alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYME alerts
High impacting Zymeworks Inc. news events
Weekly update
A roundup of the hottest topics
ZYME
News
- Levi & Korsinsky Reminds Zymeworks Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ZYMEAccesswire
- Levi & Korsinsky Reminds Zymeworks Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ZYMEAccesswire
- Lost Money on Zymeworks Inc.(ZYME)? You May Have Been Affected by Fraud- Contact Levi & KorsinskyAccesswire
- Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME)Business Wire
- Levi & Korsinsky Reminds Zymeworks Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ZYMEAccesswire
ZYME
Earnings
- 5/2/24 - Miss
ZYME
Sec Filings
- 5/3/24 - Form 8-K
- 5/3/24 - Form 424B5
- 5/3/24 - Form 424B5
- ZYME's page on the SEC website